EP05.02-002 Who Benefits More of Durvalumab after Chemoradiotherapy (CRT) in Real-World Patients with Locally Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  1. Tavara, B.
  2. Garrido, M.L.
  3. Rodríguez, Z.
  4. Rojas, M.
  5. López, L.
  6. Medina, S.
  7. Ponte, C.
  8. Lopez, A.
  9. Sanchez, E.
  10. Pedraza, M.
  11. Viñals, P.
  12. López, M.
  13. Alonso, D.
  14. Rodríguez, A.
  15. Davila, E.
  16. Castañon, C.
  17. De Sande, L.M.
  18. Nieto, B.
  19. Vallejo Pascual, M.E. 1
  20. Rodríguez, J.d.l.R.
  21. Garcia Palomo, A.
  22. Diz Taín, P.
  1. 1 Universidad de León
    info

    Universidad de León

    León, España

    ROR https://ror.org/02tzt0b78

Journal:
Journal of Thoracic Oncology

ISSN: 1556-0864

Year of publication: 2022

Volume: 17

Issue: 9

Pages: S283

Type: Article

DOI: 10.1016/J.JTHO.2022.07.484 GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Journal of Thoracic Oncology